BusinessAegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain MedicationsBy Nasdaq OMXFeb 22, 2018, 1:02 PM UTC
BusinessMucodel Pharma Announces Successful Completion of Buccal Naloxone Pilot Clinical StudyBy Nasdaq OMXSep 21, 2016, 11:45 AM UTC
BusinessLightlake Therapeutics Inc.Announces Adapt Pharma Limited to Offer All U.S. High Schools a Free Narcan® (Naloxone Hydrochloride) Nasal Spray and Fund School-Based Opioid Overdose EducationBy Nasdaq OMXJan 27, 2016, 2:00 PM UTC
BusinessLightlake Therapeutics Inc. Announces Adapt Pharma Limited Facilitates NARCAN® (Naloxone Hydrochloride) Nasal Spray Access to 62,000 State and Local Public EntitiesBy Nasdaq OMXJan 19, 2016, 2:02 PM UTC
